You can add it to a protocol without introducing hormonal complications, which means no post-cycle therapy, no aromatase concerns, and no need to monitor sex hormone panels beyond what you'd already do routinely
In addition, researchers determined that participants taking retatrutide had not yet reached a weight loss plateau at 80 weeks, meaning continued treatment would likely produce further weight loss
Keywords: BMI, GLP-1 agonists, headache, idiopathic intracranial hypertension (IIH), meta-analysis Plain language summary Can a type of diabetes and weight-loss drug help with idiopathic intracranial hypertension (IIH)
Heres how this oral medication compares to the current GLP-1 treatments approved for weight loss: What will orforglipron cost
Telehealth programs that bundle consultation, prescription, medication, and delivery into one monthly fee typically offer the best overall value
MedlinePlus also flags dehydration as a key concern with diarrhea and lists warning signs that warrant medical attention
